Relation between serum thrombospondin-2 and cardiovascular mortality in older men screened for abdominal aortic aneurysm

American Journal of Cardiology

Volumn 111, Issue 12, 2013, Pages 1800-1804

  Golledge, Jonathan ^a   Clancy, Paula ^a   Hankey, Graeme J ^b   Norman, Paul E ^c  

^a JAMES COOK UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOSPONDIN 1; THROMBOSPONDIN 2;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; FOLLOW UP; HUMAN; HYPERTENSION; IMMUNOASSAY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; AORTIC ANEURYSM, ABDOMINAL; BIOLOGICAL MARKERS; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; PROPORTIONAL HAZARDS MODELS; THROMBOSPONDIN 1; THROMBOSPONDINS; WESTERN AUSTRALIA;

EID: 84878833516     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.02.038     Document Type: Article

References (30)

1. M.W. Schellings, Y.M. Pinto, and S. Heymans Matricellular proteins in the heart: possible role during stress and remodeling Cardiovasc Res 64 2004 24 31
2. L.C. Armstrong, and P. Bornstein Thrombospondins 1 and 2 function as inhibitors of angiogenesis Matrix Biol 22 2003 63 71
3. J. Lawler The functions of thrombospondin-1 and-2 Curr Opin Cell Biol 12 2000 634 640
4. O.I. Stenina, and E.F. Plow Counterbalancing forces: what is thrombospondin-1 doing in atherosclerotic lesions? Circ Res 103 2008 1053 1055
5. T.A. Rege, J. Stewart Jr., B. Dranka, E.N. Benveniste, R.L. Silverstein, and C.L. Gladson Thrombospondin-1-induced apoptosis of brain microvascular endothelial cells can be mediated by TNF-R1 J Cell Physiol 218 2009 94 103
6. A. Oganesian, L.C. Armstrong, M.M. Migliorini, D.K. Strickland, and P. Bornstein Thrombospondins use the VLDL receptor and a nonapoptotic pathway to inhibit cell division in microvascular endothelial cells Mol Biol Cell 19 2008 563 571
7. K. Motegi, K. Harada, G. Ohe, S.J. Jones, I.R. Ellis, D.H. Crouch, S.L. Schor, and A.M. Schor Differential involvement of TGF-beta1 in mediating the motogenic effects of TSP-1 on endothelial cells, fibroblasts and oral tumour cells Exp Cell Res 314 2008 2323 2333
8. J.S. Isenberg, D.A. Wink, and D.D. Roberts Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses Cardiovasc Res 71 2006 785 793
9. T. Ichii, H. Koyama, S. Tanaka, A. Shioi, Y. Okuno, S. Otani, and Y. Nishizawa Thrombospondin-1 mediates smooth muscle cell proliferation induced by interaction with human platelets Arterioscler Thromb Vasc Biol 22 2002 1286 1292
10. J.S. Isenberg, M.J. Calzada, L. Zhou, N. Guo, J. Lawler, X.Q. Wang, W.A. Frazier, and D.D. Roberts Endogenous thrombospondin-1 is not necessary for proliferation but is permissive for vascular smooth muscle cell responses to platelet-derived growth factor Matrix Biol 24 2005 110 123
11. I. Staniszewska, S. Zaveri, L. Del Valle, I. Oliva, V.L. Rothman, S.E. Croul, D.D. Roberts, D.F. Mosher, G.P. Tuszynski, and C. Marcinkiewicz Interaction of alpha9beta1 integrin with thrombospondin-1 promotes angiogenesis Circ Res 100 2007 1308 1316
12. M. Streit, P. Velasco, L.F. Brown, M. Skobe, L. Richard, L. Riccardi, J. Lawler, and M. Detmar Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas Am J Pathol 155 1999 441 452
13. R. Moura, M. Tjwa, P. Vandervoort, S. Van Kerckhoven, P. Holvoet, and M.F. Hoylaerts Thrombospondin-1 deficiency accelerates atherosclerotic plaque maturation in ApoE-/- mice Circ Res 103 2008 1181 1189
14. M. Swinnen, D. Vanhoutte, G.C. Van Almen, N. Hamdani, M.W. Schellings, J. D'hooge, J. Van der Velden, M.S. Weaver, E.H. Sage, P. Bornstein, F.K. Verheyen, T. VandenDriessche, M.K. Chuah, D. Westermann, W.J. Paulus, F. Van de Werf, B. Schroen, P. Carmeliet, Y.M. Pinto, and S. Heymans Absence of thrombospondin-2 causes age-related dilated cardiomyopathy Circulation 120 2009 1585 1597
15. B. Schroen, S. Heymans, U. Sharma, W.M. Blankesteijn, S. Pokharel, J.P. Cleutjens, J.G. Porter, C.T. Evelo, R. Duisters, R.E. van Leeuwen, B.J. Janssen, J.J. Debets, J.F. Smits, M.J. Daemen, H.J. Crijns, P. Bornstein, and Y.M. Pinto Thrombospondin-2 is essential for myocardial matrix integrity: increased expression identifies failure-prone cardiac hypertrophy Circ Res 95 2004 515 522
16. D.M. Smadja, C. d'Audigier, I. Bièche, S. Evrard, L. Mauge, J.V. Dias, J. Labreuche, I. Laurendeau, B. Marsac, B. Dizier, O. Wagner-Ballon, C. Boisson-Vidal, V. Morandi, J.P. Duong-Van-Huyen, P. Bruneval, F. Dignat-George, J. Emmerich, and P. Gaussem Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties Arterioscler Thromb Vasc Biol 31 2011 551 559
17. M.W. Shafer, L. Mangold, A.W. Partin, and B.B. Haab Antibody array profiling reveals serum TSP-1 as a marker to distinguish benign from malignant prostatic disease Prostate 67 2007 255 267
18. G.J. Byrne, K.E. Hayden, G. McDowell, H. Lang, C.C. Kirwan, L. Tetlow, S. Kumar, and N.J. Bundred Angiogenic characteristics of circulating and tumoural thrombospondin-1 in breast cancer Int J Oncol 31 2007 1127 1132
19. M.C. Rico, J.M. Manns, J.B. Driban, A.B. Uknis, S.P. Kunapuli, and R.A. DelaCadena Thrombospondin-1 and transforming growth factor beta are pro-inflammatory molecules in rheumatoid arthritis Transl Res 152 2008 95 98
20. R.F. Macko, A.C. Gelber, B.A. Young, M.H. Lowitt, B. White, F.M. Wigley, and S.E. Goldblum Increased circulating concentrations of the counter adhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation J Rheumatol 29 2002 2565 2570
21. A.Z. Dudek, and H. Mahaseth Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survival Cancer Invest 23 2005 193 200
22. J.V. Moxon, M.P. Padula, P. Clancy, T.I. Emeto, B.R. Herbert, P.E. Norman, and J. Golledge Proteomic analysis of intra-arterial thrombus secretions reveals a negative association of clusterin and thrombospondin-1 with abdominal aortic aneurysm Atherosclerosis 219 2011 432 439
23. M. Navarro-Sobrino, A. Rosell, M. Hernández-Guillamon, A. Penalba, C. Boada, S. Domingues-Montanari, M. Ribó, J. Alvarez-Sabín, and J. Montaner A large screening of angiogenesis biomarkers and their association with neurological outcome after ischemic stroke Atherosclerosis 216 2011 205 211
24. B. Stenczer, A. Molvarec, Z. Veresh, N. Gullai, G.R. Nagy, S. Walentin, J. Szijártó, and J. JánosRigó Circulating levels of the anti-angiogenic thrombospondin-2 (TSP-2) are elevated in preeclampsia Acta Obstet Gynecol Scand 90 2011 1291 1295
25. P.E. Norman, L. Flicker, O.P. Almeida, G.J. Hankey, Z. Hyde, and K. Jamrozik Cohort Profile: The Health In Men Study (HIMS) Int J Epidemiol 38 2009 48 52
26. J. Golledge, P. Clancy, K. Jamrozik, and P.E. Norman Obesity, adipokines, and abdominal aortic aneurysm: Health In Men Study Circulation 116 2007 2275 2279
27. J. Golledge, F. van Bockxmeer, K. Jamrozik, M. McCann, and P.E. Norman Association between serum lipoproteins and abdominal aortic aneurysm Am J Cardiol 105 2010 1480 1484
28. P.E. Norman, K. Jamrozik, M.M. Lawrence-Brown, M.T. Le, C.A. Spencer, R.J. Tuohy, R.W. Parsons, and J.A. Dickinson Population based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm BMJ 329 2004 1259
29. J. Golledge, and P.E. Norman Pathophysiology of abdominal aortic aneurysm relevant to improvements in patients' management Curr Opin Cardiol 24 2009 532 538
30. P.A. Tooney, T. Sakai, K. Sakai, D. Aeschlimann, and D.F. Mosher Restricted localization of thrombospondin-2 protein during mouse embryogenesis: a comparison to thrombospondin-1 Matrix Biol 17 1998 131 143